KLK4 and Alzheimer disease: The top hit between AD and HC groups, KLK4, kallikrein‐related peptidase 4, has been implicated in many types of cancer and has potential as a tumor biomarker [37, 38, 39] which also predicts short‐term relapse in colorectal adenocarcinoma patients [40].